Quick Answer Accustem Sciences Inc. reported Operating Income of -$1.51 million for fiscal year 2024. Accustem Sciences Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2024 -$1.51M +26.6% 2023 -$2.05M +45.3% 2022 -$3.75M -458.7% 2021 -$670.6K — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ September 30, 2025 -$399.9K -21.9% … Read more
Quick Answer Accustem Sciences Inc. reported R&D Expense of $138.3 thousand for fiscal year 2024. Accustem Sciences Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2024 $138.3K -1.0% 2023 $139.7K -47.7% 2022 $266.9K +264.0% 2021 $73.3K — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ September 30, 2025 $72.7K +131.5% … Read more
Quick Answer Accustem Sciences Inc. reported Stockholders Equity of -$3.31 million for fiscal year 2024. Accustem Sciences Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2024 -$3.31M -56.9% 2023 -$2.11M -1413.1% 2022 -$139.6K -121.4% 2021 $650.7K -50.3% 2020 $1.31M — Quarterly Stockholders Equity Quarter Ending Stockholders Equity YoY QoQ September 30, … Read more
Quick Answer Accustem Sciences Inc. reported Total Assets of $50.9 thousand for fiscal year 2024. Accustem Sciences Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2024 $50.9K -62.0% 2023 $133.9K -85.8% 2022 $939.7K -30.6% 2021 $1.35M — Quarterly Total Assets Quarter Ending Total Assets YoY QoQ September 30, 2025 $1.57M +1415.4% … Read more
Quick Answer Accustem Sciences Inc. reported Net Income of -$1.51 million for fiscal year 2024. Accustem Sciences Inc. — Key Financials by Year Metric 2024 2023 2022 2021 2020 Net Income -$1.51M+26.6% -$2.05M+45.3% -$3.75M-458.7% -$670.6K — Diluted EPS -$0.13+27.8% -$0.18+47.1% -$0.34 — — Total Assets $50.9K-62.0% $133.9K-85.8% $939.7K-30.6% $1.35M — Stockholders Equity -$3.31M-56.9% -$2.11M-1413.1% -$139.6K-121.4% … Read more
Quick Answer Accustem Sciences Inc. reported Net Income of -$1.51 million for fiscal year 2024. Accustem Sciences Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2024 -$1.51M +26.6% 2023 -$2.05M +45.3% 2022 -$3.75M -458.7% 2021 -$670.6K — Quarterly Net Income Quarter Ending Net Income YoY QoQ September 30, 2025 -$399.9K -21.9% … Read more
Quick Answer Accustem Sciences Inc. reported Diluted EPS of $0.13 per share (loss) for fiscal year 2024. Accustem Sciences Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2024 -$0.13 +27.8% 2023 -$0.18 +47.1% 2022 -$0.34 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ September 30, 2025 -$0.02 +33.3% +0.0% … Read more
Quick Answer ACME UNITED CORP reported Gross Profit of $77.41 million for fiscal year 2025. ACME UNITED CORP Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $77.41M +1.4% 2024 $76.35M +5.7% 2023 $72.21M +13.6% 2022 $63.56M -1.9% 2021 $64.80M +8.7% 2020 $59.59M +14.6% 2019 $52.00M +2.7% 2018 $50.65M +5.7% 2017 $47.90M … Read more
Quick Answer ACME UNITED CORP reported Shares Outstanding of 3.81 million shares for fiscal year 2025. ACME UNITED CORP Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 3.81M +1.4% 2024 3.75M +3.0% 2023 3.65M +3.0% 2022 3.54M +0.5% 2021 3.52M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ September … Read more
Quick Answer ACME UNITED CORP reported Operating Income of $14.72 million for fiscal year 2025. ACME UNITED CORP Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $14.72M +4.1% 2024 $14.14M +7.2% 2023 $13.19M +110.2% 2022 $6.27M -50.9% 2021 $12.77M +11.9% 2020 $11.41M +35.4% 2019 $8.43M +13.0% 2018 $7.46M -5.4% 2017 $7.88M … Read more